REFERENCES
- Cornell B. A., Middlehurst J., Separovic F. Small unilamellar phospholipid vesicles and the theory of membrane formation. Faraday Disc. Chem. Soc. 1986; 81: 163–167, [CSA]
- Dong C. Study on distribution of 3H-norcantharidin in mice. J. Acad. Med. Jiangxi 1984; 24: 3–6, [CSA]
- Hao J. Effect of the structures of microemulsions on chemical reactions. Colloid Polym. Sci. 2000; 278: 150–154, [CROSSREF], [CSA]
- Israelachvidi J. N., Mitchell D. J., Ninham B. W. Theory of self-assembly of hydrocarbon amphilphiles into micelles and bilayers. J. Chem. Soc. Faraday Trans. 1976; 72: 1525–1568, [CROSSREF], [CSA]
- Kenji A., Tomohiro H. Effect of adding an amphiphilic solubilization improver, sucrose distearate, on the solubilization capacity of nonionic microemulsions. J. Colloid Interface Sci. 2001; 236: 14–19, [CROSSREF], [CSA]
- Mueller-Goymann C. C., Hamenn H. J. Sustained release from reverse micellar solutions by phase transformations into lamellar liquid crystal. J. Control. Release 1993; 23: 165–174, [CROSSREF], [CSA]
- Park K. M., Lee M. K., Hwang K. J., Kim C. K. Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm. 1999; 183: 145–154, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shigeru K., Nao O., Ryu H. Biodistribution and pharmacokinetics of 0-palmitoyl tilisolol, a lipophilic prodrug of tilisolol, after intravenous administration in Rats. Biol. Pharm. Bull. 2002; 25(8)1072–1076, [CROSSREF], [CSA]
- Trotta M., Gallarate M., Gasco M. R. Effect of the variation of microemulsion water content on the in vitro permeation of hydrocortisone. Acta Tecnol. Legis Medicamenti. 1995; 6: 67–78, [CSA]
- Uif O., Kozo S. Change of the structure of microemulsions with the hydrophile-lipophile balance of nonconic surfactant as revealed by NMR self-diffusion studies. J. Phys. Chem. 1986; 90: 4083–4088, [CROSSREF], [CSA]
- Wakiyama N., Juni K., Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chem. Pharm. Bull. 1981; 29: 3363–3368, [PUBMED], [INFOTRIEVE], [CSA]
- Wang G. S. Hydrolyze of norcantharidin and subtracting methyla alleviates stimulation of renal system. J. Acta Pharmaceutica Sinica 1983; 7: 18–22, [CSA]
- Wang J. X., Sun X., Zhang Z. R. Enhanced brain targeting by synthesis of 3,5-dioctanoyl-5fluoro-2-deoxyuridine and incorporation into solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2002; 54(3)285–290, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang L., Sun X., Xiang D., Zhang Z. R. Formulation and physicochemical characterization of norcantharidin microemulsion containing medium-chain length glycerides and phospholipid-based surfactants. J. Drug Del. Sci. Tech. 2004; 14(6)461–469, [CSA]